Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.Sweta Chekuri, Alexis F. Turgeon, Jorge Escobedo et al.|Bristol Research (University of Bristol)|2021Cited by 589
The<i>Staphylococcus aureus</i>Network Adaptive Platform Trial Protocol: New Tools for an Old FoeSteven Y. C. Tong, Adrian Dunlop, Jocelyn Mora et al.|Clinical Infectious Diseases|2022Cited by 98
Elucidating the clinical characteristics of patients captured using different definitions of massive transfusionAmanda J. Zatta, Louise Phillips, Zoe McQuilten et al.|Vox Sanguinis|2014Cited by 96
Therapeutic Anticoagulation in Non-Critically Ill Patients with Covid-19Ryan Zarychanski, Patrick R. Lawler, Ewan C. Goligher et al.|medRxiv|2021Cited by 19
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditionsJeremy W. Jacobs, Brian D. Adkins, Garrett S. Booth et al.|American Journal of Hematology|2024Cited by 15